GeneDx Holdings Corp. Class A Common Stock (WGS) News
Latest headlines that mention WGS, newest first · each headline opens the original publisher
- Last price
- $68.94
- Day change
- +0.29%
- Next earnings
- 2026-10-27
WGS headlines
latest coverageGenomic testing volume surged 32% as profitability returned ahead of schedule.
GeneDx leverages AI-driven analytics for healthcare insights; a key insider recently trimmed their stake, according to SEC filings.
GeneDx Holdings, known for AI-driven health data, reported a notable insider buy amid continued momentum in precision medicine services.
GeneDx Holdings delivers AI-powered clinical and genomic data analysis for healthcare providers seeking precision medicine solutions.
AI-driven health intelligence provider GeneDx attracted a notable insider buy, as recent filings highlight activity amid a volatile year.
GeneDX's latest quarterly report arrived with a lot of bad news for investors.
GeneDx stock crashed Tuesday on what one analyst called its "alarming" first-quarter sales miss, leading to a guidance cut for the year. The post The 'Alarming' Results That Caused GeneDx Stock To Plummet 49% appeared first on Investor's Business Daily .
WGS news alerts
Get an alert by email or push when a new headline mentions WGS.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.